The left ventricular expression of the pro-hypertrophic myocyte enhancer factor 2 C (Mef2c) and myocyte enhancer factor 2D (Mef2d) did not increase in the CKD group as compared to the sham group (Table 4). Here, MEF2D is linked to chronic kidney disease.